All for Joomla
All for Webmasters
Hemostasis
Acute Care Diagnostics
Autoimmunity
Transfusion
Transplant
#GiveToGain
WTDay
Cyber Health
EEMEA Learning Center - thrombosis
HIV and Thrombosis
Read more...
Artificial Intelligence (AI) and Machin-Learning in Thrombosis and Hemostasis
Read more...
Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation: Results From the PTRG-DES Consortium
Read more...
ADAMTS-13/VWF as biomarker for Portal Vein Thrombosis development in cirrhotic patients
Read more...
Monitoring of COVID-19-Associated Coagulopathy and Anticoagulation with Thromboelastometry
Read more...
Hemostasis in Coronavirus Disease 2019-Lesson from Viscoelastic Methods: A Systematic Review
Read more...
Dynamic Hemostasis and Fibrinolysis Assays in Intensive Care COVID-19 Patients and Association with Thrombosis and Bleeding-A Systematic Review and a Cohort Study
Read more...
Hemostasis in Coronavirus Disease 2019-Lesson from Viscoelastic Methods: A Systematic Review
Read more...
Viscoelastic testing reveals normalization of the coagulation profile 12 weeks after severe COVID-19
Read more...
D3 - Session 5 - D-Dimer and Arterial Diseases
Read more...
D3 - Session 4 - D-Dimer in Cancer and VTE
Read more...
D3 - Session 3 - Analytical Aspects of D-Dimer Assays
Read more...
D3 - Session 2 - General Overview of Fibrinolysis
Read more...
D3 - Session 1 - Covid19 Associated Coagulopathies: A Year in Review
Read more...
Management of antiplatelet therapy in patients undergoing neuroendovascular procedures
Read more...
Laboratory assessments of therapeutic platelet inhibition in endovascular neurosurgery: complication prediction using the VerifyNow P2Y12 assay and thromboelastography with platelet mapping
Read more...
Initial experience with the novel p64MW HPC flow diverter from a cohort study in unruptured anterior circulation aneurysms under dual antiplatelet medication
Read more...
Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collabo
Read more...
Percutaneous Coronary Intervention With an Initial Bolus of Low-Dose Heparin in Biomarker-Negative Patients
Read more...
Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial
Read more...
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study
Read more...
Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis
Read more...
Aspirin unresponsiveness predicts thrombosis in high-risk pediatric patients after cardiac surgery
Read more...
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention
Read more...
Assessment of Bleeding and Thrombosis Based on Aspirin Responsiveness after Continuous-Flow Left Ventricular Assist Device Placement
Read more...
The effect of correcting VerifyNow P2Y12 assay results for hematocrit in patients undergoing percutaneous coronary interventions
Read more...
Antiplatelet Therapy Bridging With Cangrelor in Patients With Coronary Stents: A Case Series
Read more...
Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
Read more...
Novel use of cangrelor in pediatrics: A pilot cohort study demonstrating use in ventricular assist devices
Read more...
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the Euro
Read more...
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y 12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention
Read more...
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients
Read more...
Venous thromboembolism in critically Ill patients with COVID-19: Results of a screening study for deep vein thrombosis
Read more...
COVID-19 Related Coagulopathy: A Distinct Entity?
Read more...
COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure
Read more...
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET)
Read more...
Fibrinolysis and COVID‐19: A plasmin paradox
Read more...
Viral infections and their relationship with catastrophic antiphospholipid syndrome: a possible pathogenic mechanism of severe COVID-19 thrombotic complications
Read more...
Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients
Read more...
Coagulopathy in COVID-19: Posted april 24, 2020
Read more...
Heparin - An old drug with multiple potential targets in Covid-19 therapy
Read more...
Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis
Read more...
Dynamic relationship between D-dimer and COVID-19 severity
Read more...
Coagulation abnormalities and thrombosis in patients with COVID-19
Read more...
Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis
Read more...
Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS-CoV-2 infection
Read more...
Potential role of platelets in COVID-19: Implications for thrombosis
Read more...
Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID‐19
Read more...
Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic
Read more...
Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus
Read more...
Coagulopathy in COVID-19
Read more...
High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability?
Read more...
The unique characteristics of COVID-19 coagulopathy
Read more...
Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence
Read more...
Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19
Read more...
Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19
Read more...
Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis
Read more...
Heparin-induced thrombocytopenia with thrombosis in COVID-19 adult respiratory distress syndrome
Read more...
Frequency of lupus anticoagulant in COVID-19 patients
Read more...
Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis
Read more...
Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence
Read more...
COVID-19 Related Arterial Coagulopathy
Read more...
Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation
Read more...
COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure
Read more...
Macrothrombosis and stroke in patients with mild Covid‐19 infection
Read more...
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19
Read more...
Antiphospholipid antibodies in patients with COVID‐19: A relevant observation?
Read more...
Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolism
Read more...
Coronavirus Disease 2019 (COVID-19) Infection Associated With Antiphospholipid Antibodies and Four-Extremity Deep Vein thrombosis in a Previously Healthy Female
Read more...
The vascular side of COVID-19 disease. Position paper of the International Union of Angiology
Read more...
Hypoxia-An overlooked trigger for thrombosis in COVID-19 and other critically ill patients
Read more...
A proposal for staging COVID-19 coagulopathy
Read more...
COVID-19-associated coagulopathy: An exploration of mechanisms
Read more...
Understanding the COVID-19 coagulopathy spectrum
Read more...
The protective rather than prothrombotic fibrinogen in COVID-19 and other inflammatory states
Read more...
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
Read more...
Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review)
Read more...
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
Read more...
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Read more...
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Read more...
COVID-19 and acute coagulopathy in pregnancy
Read more...
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia
Read more...
Prevalence, specificity, and clinical association of anti-phospholipid antibodies in COVID-19 patients: are the antibodies really guilty?
Read more...
Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis
Read more...
Thrombosis and Coagulopathy in COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation
Read more...
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
Read more...
Heparin-induced thrombocytopenia in COVID-19 patients with severe acute respiratory distress syndrome requiring extracorporeal membrane oxygenation: two case reports
Read more...
Response to "All these D-dimers in COVID-19"
Read more...
Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation
Read more...
Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology
Read more...
Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia
Read more...
Heparin resistance in COVID-19 patients in the intensive care unit
Read more...
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors
Read more...
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
Read more...
Direct oral anticoagulant plasma levels' striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents: The Cremona experience
Read more...
Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays
Read more...
Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis
Read more...
Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis
Read more...
COVID-19-Related Aortic Thrombosis: A Report of Four Cases
Read more...
Start
Prev
1
2
Next
End
Page 1 of 2
Werfen.com.
All rights Reserved.
Privacy Policy
|
Cookies Policy
|
Terms of Service
No Internet Connection